Evidence map›Paper›PMID 31071965›Full record

ReviewCells2019

A Review of Macrophage MicroRNAs' Role in Human Asthma.

Gavriela Feketea, Corina I Bocsan, Cristian Popescu, Mihaela Gaman, Luminita A Stanciu, Mihnea T Zdrenghea

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Exploration of the Molecular Mechanisms ofBioMed research international · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Extracellular Vesicles and Asthma-More Than Just a Co-Existence.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gavriela FeketeaDepartment of Hematology, Iuliu Haţieganu University of Medicine and Pharmacy, 400124 Cluj-Napoca, Romania. Fechetea.Gabriela@umfcluj.ro.ORCID 0000-0001-9026-2597
Corina I BocsanDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania. bocsan.corina@umfcluj.ro.
Cristian PopescuDepartment of Hematology, Iuliu Haţieganu University of Medicine and Pharmacy, 400124 Cluj-Napoca, Romania. popescu.cristian@umfcluj.ro.ORCID 0000-0003-3015-9023
Mihaela GamanDepartment of Hematology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. mihaela_dervesteanu@yahoo.com.
Luminita A StanciuNational Heart and Lung Institute, Imperial College London, London W2 1PG, UK. l.stanciu@imperial.ac.uk.
Mihnea T ZdrengheaDepartment of Hematology, Iuliu Haţieganu University of Medicine and Pharmacy, 400124 Cluj-Napoca, Romania. mzdrenghea@umfcluj.ro.ORCID 0000-0002-9461-987X
Iuliu Hațieganu University of Medicine and Pharmacy · ROCarol Davila University of Medicine and Pharmacy · ROImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an imbalance in asthma between classically activated macrophages (M1 cells) and alternatively activated macrophages (M2 cells) in favor of the latter. MicroRNAs (miRNAs) play a critical role in regulating macrophage proliferation and differentiation and control the balance of M1 and M2 macrophage polarization, thereby controlling immune responses. Here we review the current published data concerning miRNAs with known correlation to a specific human macrophage phenotype and polarization, and their association with adult asthma. MiRNA-targeted therapy is still in the initial stages, but clinical trials are under recruitment or currently running for some miRNAs in other diseases. Regulating miRNA expression via their upregulation or downregulation could show potential as a novel therapy for improving treatment efficacy in asthma.

Indexed as

AsthmaBiomarkersHumansMacrophagesMicroRNAsRNA, MessengerBiomarkersMicroRNAsRNA, MessengerasthmamacrophagesmicroRNAmolecular asthma

Identifiers

PMID31071965
PMCPMC6562863
OpenAlexW2944609921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.